Patterson Companies Inc (PDCO)
20.28
+0.22
(+1.10%)
USD |
NASDAQ |
Nov 21, 16:00
20.28
0.00 (0.00%)
After-Hours: 20:00
Patterson Revenue (Quarterly): 1.542B for July 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 1.542B |
| April 30, 2024 | 1.723B |
| January 31, 2024 | 1.616B |
| October 31, 2023 | 1.653B |
| July 31, 2023 | 1.577B |
| April 30, 2023 | 1.721B |
| January 31, 2023 | 1.601B |
| October 31, 2022 | 1.626B |
| July 31, 2022 | 1.523B |
| April 30, 2022 | 1.639B |
| January 31, 2022 | 1.597B |
| October 31, 2021 | 1.649B |
| July 31, 2021 | 1.615B |
| April 30, 2021 | 1.562B |
| January 31, 2021 | 1.551B |
| October 31, 2020 | 1.553B |
| July 31, 2020 | 1.246B |
| April 30, 2020 | 1.286B |
| January 31, 2020 | 1.456B |
| October 31, 2019 | 1.419B |
| July 31, 2019 | 1.329B |
| April 30, 2019 | 1.437B |
| January 31, 2019 | 1.397B |
| October 31, 2018 | 1.405B |
| July 31, 2018 | 1.336B |
| Date | Value |
|---|---|
| April 30, 2018 | 1.401B |
| January 31, 2018 | 1.375B |
| October 31, 2017 | 1.386B |
| July 31, 2017 | 1.304B |
| April 30, 2017 | 1.445B |
| January 31, 2017 | 1.397B |
| October 31, 2016 | 1.418B |
| July 31, 2016 | 1.332B |
| April 30, 2016 | 1.454B |
| January 31, 2016 | 1.401B |
| October 31, 2015 | 1.389B |
| July 31, 2015 | 1.143B |
| April 30, 2015 | 1.035B |
| January 31, 2015 | 958.63M |
| October 31, 2014 | 978.22M |
| July 31, 2014 | 938.96M |
| April 30, 2014 | 623.50M |
| January 31, 2014 | 1.083B |
| October 31, 2013 | 998.83M |
| July 31, 2013 | 880.12M |
| April 30, 2013 | 964.93M |
| January 31, 2013 | 915.86M |
| October 31, 2012 | 867.19M |
| July 31, 2012 | 889.22M |
| April 30, 2012 | 936.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.246B
Minimum
Jul 2020
1.723B
Maximum
Apr 2024
1.565B
Average
1.597B
Median
Jan 2022
Revenue (Quarterly) Benchmarks
| Standard BioTools Inc | 44.97M |
| Ainos Inc | -- |
| Zomedica Corp | 6.997M |
| LENSAR Inc | 13.54M |
| Intelligent Bio Solutions Inc | 0.8723M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 13.72M |
| Total Expenses (Quarterly) | 1.512B |
| EPS Diluted (Quarterly) | 0.15 |
| Enterprise Value | 2.392B |
| Gross Profit Margin (Quarterly) | 20.28% |
| Profit Margin (Quarterly) | 0.89% |
| Earnings Yield | 9.02% |
| Operating Earnings Yield | 13.12% |
| Normalized Earnings Yield | 8.009 |